With 3' Seq you normally don't need length normalisation. You get - simply spoken - one read per transcript copy. The reads may be directly in the 3' UTR or are spanning junctions further downstream. In this regard, it's more like tag-counting than full-length RNA sequencing with abundance estimation.
If you have spike-in controls (like the ERCCs), I'd check these for the expected vs. observed expression.
You could also check BioGPS for the highly expressed genes, if they are known to be highly expressed in your given tissue.
Probably not. If these genes are known to have high expression values and it's consistent along samples you shouldn't be worried.